Fierce Pharma July 4, 2022
Six weeks ago, when Pfizer said it would provide 23 of its drugs to 45 of the world’s poorest nations at a not-for-profit price, CEO Albert Bourla urged others in his Big Pharma orbit to hop on the bandwagon.
Not to be outdone is Sanofi, which launched a similar effort more than a year ago and is now expanding the initiative.
The Paris-based drugmaker is creating a fund that will support startups that aim to deliver healthcare solutions in underserved regions. The goal is to help establish local entities that can be sustainable.
This whitepaper explores how duplicate discounts from drug discount programs adversely impact drug manufacturer finances, why the...
Today's Sponsors
Today's Sponsor